Avicanna

Academy

Reliable Resources on Cannabinoid
Research and Clinical Development

Avicanna’s 3rd Annual Symposium Review
Medical Cannabis 2.0 – The Advancements in Cannabinoid Research, Product Offerings, and Patient Access

September 23rd, 2020
The 3rd annual Avicanna Symposium, “Medical Cannabis 2.0 – The Advancements in Cannabinoid Research, Product Offerings, and Patient Access”, was held virtually due to COVID-19 restrictions on the 21st of July, 2020. The purpose of the Symposium was to highlight the current state of advancements in the medical cannabis industry in Canada and abroad as well as underlining the key areas of research and product development. In addition, the speakers address patient access for medical cannabis products currently being offered on the market. This event brought together more than 1,000 participants including clinicians, researchers, regulatory affairs specialists, investors, members of the pharmaceutical industry and key representatives in the Canadian cannabis field.